VANCOUVER, BC / ACCESSWIRE / January 26, 2017 / CVR Medical Corp. CVR Medical Corp. (TSX.V:CVM) (FRANKFURT: B3BN) (OTCQB: CRRVF) (“CVR Medical“) has retained the services of Cozen O’Connor. The Philadelphia-based law firm will work with CVR to obtain and protect patents related to the technology being implemented in the “Carotid Stenotic Scan (CSS)” device.
One of the largest and most successful law firms in the United States, Cozen O’Connor has built a global brand with a diverse list of clients across varying industries. Their expertise with patent law specific to the fields of science and medicine will lend support and defense to CVR’s intellectual property as it goes through the process of FDA approvals. In addition, the firm’s experience managing patent portfolios for companies in early-growth stages will strengthen CVR’s position as it moves beyond market launch of the CSS. CVR Medical CEO Peter Bakema, on this partnership, states, “It has always been of great importance to us to have the best practices, and the best people, in place to protect this incredible technology we’ve developed. We could not be happier to have found those people at Cozen O’Connor, and we look forward to having their guidance to help maximize the opportunities that technology presents.”
On behalf of Cozen O’Connor, Mr. Kyle Vos Strache states, “There’s real risk to being a pioneer, to challenging the status quo. What we see in the CVR team is a dedication to developing and implementing a technology that can really change the healthcare industry. We’re excited to be a part of that, and for us that means being proactive and ready to protect the product, as well as the company, as they evolve.”
For additional information on the organization, leadership, and current news please visit the newly launched company website www.CVRMed.com
About CVR Medical
CVR Medical is a company that is involved in an equal parts joint venture with CVR Global Inc. (the “Joint Venture”). The Joint Venture operates in the medical industry focused on the commercialization of a proprietary subsonic, infrasonic, and low frequency sound wave analysis technology and has patents to a diagnostic device designed to detect and measure carotid arterial stenosis. CVR Medical is managed by a proven technical team. CVR Medical trades on the TSX Venture Exchange under the symbol CVM.
For further information contact:
Brisco Capital Partners Corp.
Scott Koyich, President
Telephone: (403) 262-9888